News & Insights
The latest updates, research highlights, and press announcements from Quantum Biosciences
9/1/2026
NASSCOM Emerge 50 Winner
Top Honors in Healthtech & Life Sciences (2026)
more...
9/1/2026
Winner, NBEC 2026 Grand Finale
Top Honors at India's Flagship Bio-Innovation Challenge
more...
2/22/2026
A Seat at the Table
Shaping the Future of Quantum Medicine with ARPA-H
more...
2/19/2026
Nobel Research Sprint 2025
Advancing Interdisciplinary Innovation at India’s Premier Medical Institution – AIIMS, Delhi (14–15 February 2026 @ The National Centre for Ageing (NCA), AIIMS New Delhi)
more...
12/18/2025
Bridging Continents, Biology & Physics
QBS Journey to the Quantum Sensing Labs of Groningen
more...
11/21/2025
Quantum Biosciences Selected for Swissnex AIT 2025
Accelerating Global Validation Bridging Bengaluru and Switzerland
more...
8/24/2025
Quantum Biosciences Awarded Prestigious MeitY TIDE 2.0 Grant to Accelerate Deep-Tech Innovation
Quantum Biosciences is honored to be a recipient of the MeitY TIDE 2.0 Grant, a prestigious award from the Indian government designed to accelerate deep-tech innovation and support the national startup ecosystem.
more...
8/21/2025
Quantum Biosciences Unveils Predictive Framework for Cellular Stress Signatures at Stanford Quantum Biosensing Workshop
Our team presented our research on a multi-scale computational framework for predictive toxicology at the prestigious Stanford Workshop on Quantum Biosensing. The presentation detailed our "sim-to-real" approach to closing the "diagnostic blind window" in cancer therapy, where irreversible damage can occur long before clinical symptoms appear.
more...
7/30/2025
Quantum Biosciences Announces Strategic Partnership with QT Sense to Advance Quantum Diagnostics
Quantum Biosciences is proud to announce a strategic partnership with Netherlands-based QT Sense, a leader in quantum relaxometry systems. This collaboration was featured in today's edition of The Hans India, Bengaluru. The partnership combines Quantum Biosciences' deep expertise in computational modeling and our proprietary in-silico engine with QT Sense's state-of-the-art "Quantum Nuova" sensing hardware. By integrating these platforms, we aim to accelerate the development and validation of our predictive diagnostic tests for radiation-induced toxicity. This collaboration leverages the unique strengths of both companies to create a best-in-class solution, setting a new standard for the application of quantum sensing in personalized medicine. We are thrilled to work with the team at QT Sense to bring this transformative technology to the clinic.
more...
7/30/2025
Quantum Biosciences Highlights Core Research and Quantum Vista Initiative at QIB 2025
Quantum Biosciences is proud to be a key participant at the inaugural Quantum India Bengaluru (QIB) 2025 summit, taking place today, July 31st, and August 1st, 2025, at the Hotel Hilton, Embassy Manyata Business Park, Bengaluru.
more...